Literature DB >> 27770246

Incidence of adhesions and maternal and neonatal morbidity after repeat cesarean section.

Sefa Arlier1, Sevtap Seyfettinoğlu2, EsraSaygili Yilmaz2, Hakan Nazik2, Cevdet Adıgüzel2, Eda Eskimez3, Şerif Hürriyetoğlu2, Oğuz Yücel2.   

Abstract

PURPOSE OF INVESTIGATION: We investigated the effect of repeat cesarean sections (CSs) and intra-abdominal adhesions on neonatal and maternal morbidity.
MATERIALS AND METHODS: We analyzed intra-abdominal adhesions of 672 patients.
RESULTS: Among the patients, 173, 206, 151, and 142 underwent CS for the first, second, third, and fourth time or more, respectively. There were adhesions in 393 (58.5 %) patients. Among first CSs, there were no adhesions, the rate of maternal morbidity [Morales et al. (Am J Obstet Gynecol 196(5):461, 2007)] was 26 %, and the rate of neonatal morbidity (NM) was 35 %. Among women who have history of two CSs, the adhesion rate was 66.3 %, the adhesion score was 2.05, MM was 14 %, and NM was 21 %. Among third CSs, these values were 82.1, 2.82, 23, and 14 %, respectively. Among women who have history of four or more CSs, these values were 92.2, 4.72, 31.7, and 18 %, respectively. Adhesion sites and dense fibrous adhesions increased parallel to the number of subsequent CSs. Increased adhesion score was associated with 1.175-fold higher odds of NM and 1.29-fold higher odds of MM. The rate of NM was eightfold higher in emergency-delivered newborns (emergency: 39.4, 40 %; elective: 4.9 %). MM was 20 and 26 % for elective and emergency CSs, respectively.
CONCLUSIONS: Emergency operations and adhesions increased complications.

Entities:  

Keywords:  Intraoperative complication; Morbidity; Postoperative complication; Repeat cesarean section; Tissue adhesion

Mesh:

Year:  2016        PMID: 27770246     DOI: 10.1007/s00404-016-4221-8

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

1.  The analgesic effect of tramadol combined with butorphanol on uterine cramping pain after repeat caesarean section: a randomized, controlled, double-blind study.

Authors:  Qin Cai; Hanlin Gong; Mingbo Fan; Wen Chen; Lun Cai
Journal:  J Anesth       Date:  2020-07-05       Impact factor: 2.078

2.  The effect of uterine artery ligation in patients with central placenta pevia: a randomized controlled trial.

Authors:  Ahmad Sameer Sanad; Ahmad E Mahran; Mahmoud Elmorsi Aboulfotouh; Hany Hassan Kamel; Hashem Fares Mohammed; Haitham A Bahaa; Reham R Elkateeb; Alaa Gamal Abdelazim; Mohamed Ahmed Zeen El-Din; Hossam El-Din Shawki
Journal:  BMC Pregnancy Childbirth       Date:  2018-08-29       Impact factor: 3.007

3.  Patient-controlled intravenous tramadol versus patient-controlled intravenous hydromorphone for analgesia after secondary cesarean delivery: a randomized controlled trial to compare analgesic, anti-anxiety and anti-depression effects.

Authors:  Guangyou Duan; Xiaohang Bao; Guiying Yang; Jing Peng; Zhuoxi Wu; Peng Zhao; Zhiyi Zuo; Hong Li
Journal:  J Pain Res       Date:  2018-12-18       Impact factor: 3.133

4.  Comparison of postoperative pain between patients who underwent primary and repeated cesarean section: a prospective cohort study.

Authors:  Guangyou Duan; Guiying Yang; Jing Peng; Zhenxin Duan; Jie Li; Xianglong Tang; Hong Li
Journal:  BMC Anesthesiol       Date:  2019-10-22       Impact factor: 2.217

5.  Repeated Cesarean Delivery Predicted a Higher Risk of Inadequate Analgesia Than Primary Cesarean Delivery: A Retrospective Study with Propensity Score Match Analysis.

Authors:  Guiying Yang; Xiaohang Bao; Jing Peng; Jie Li; Guangming Yan; Sheng Jing; Hong Li; Guangyou Duan
Journal:  J Pain Res       Date:  2020-03-18       Impact factor: 3.133

6.  The Relationship Between Pre-Operative Glycosylated Haemoglobin and Opioid Consumption After Caesarean Section in Women With Gestational Diabetes Mellitus.

Authors:  Chen Yang; Yue Li; Jianying Hu; Jiangnan Wu; Shaoqiang Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.